New Onset Pancytopenia in Adults: Review of Underlying Pathologies and Associated Clinical and Laboratory Findings.
(1250)
KA Devitt, JH Lunde, MR Lewis - University of Vermont, Burlington
CD34+ Progenitor-Based Flow Cytometric Immunophenotypic Analysis Is Sensitive and Specific in Assessment of Myelodysplastic Syndromes.
(1377)
G Tang, Y Zhou, JL Jorgensen, Y Hu, K Marian, LJ Medeiros, G Garcia-Manero, SA Wang - MD Anderson, Houston, TX
Secondary MDS: p53 and CD117 in the Bone Marrow Biopsy May Be Relevant Prognostic Markers.
(1379)
RSS Tanizawa, EDRP Velloso, SAC Siqueira, R Rosenfeld, R Azevedo, VL Aldred, MCN Zerbini - University of Sao Paulo School of Medicine, SP, Brazil; UNIFESP School of Medicine, Sao Paulo, SP, Brazil
Therapy-Related Myelodysplastic Syndrome (MDS) Lacking High-Risk Karyotype Resembles De Novo Disease and Differs from Conventional Therapy-Related MDS.
(1275)
RP Hasserjian, Y OK Chi, Y Hu, M Kluk, E Attar, SA Wang - Massachusetts General Hospital, Boston; UMass Medical Center, Worcester, MA; UT MD Anderson Cancer Center, Houston, TX; Brigham & Women's Hospital, Boston, MA
Ring Sideroblasts and a Normal Karyotype in Bone Marrow of Patients Treated for Primary Malignancies and Developed Cytopenia.
(1329)
CY Ok, Y Zhou, Y Hu, LJ Medeiros, S Wang - University of Massachusetts, Worcester; UT MD Anderson Cancer Center, Houston, TX
The Pathologic Spectrum of Myelodysplastic Syndrome with Isolated del(5q): A Retrospective Study of 80 Cases.
(1234)
D Chen, JD Hoyer, MM Patnaik, RP Ketterling, A Tefferi, CA Hanson - Mayo Clinic, Rochester, MN
Clinicopathologic Study of Isolated Del(20q) in De Novo Myelodysplastic Syndrome: A Group with Favorable Prognosis and No Evidence of Common Oncogenic Mutations.
(1292)
R Kanagal Shamanna, RN Miranda, CC Yin, CE Bueso-Ramos, R Muddasani, LJ Medeiros, G Lu - UT MD Anderson Cancer Center, Houston, TX
Deletion of the Long Arm of Chromosome 20 (20q-) Is a Recurrent Genetic Marker in Acute Erythroid Leukemia.
(1420)
RM Ziegler, L Failla, FK Racke, W Zhao - The Ohio State University, Columbus
Del(20q) in Patients with Chronic Lymphocytic Leukemia Is Associated with Prior Chemotherapy, Atypical Morphology, ZAP70 Expression, and Unmutated IGHV Genes.
(1405)
CC Yin, G Lu, LJ Medeiros, X Feng, MJ Keating, LV Abruzzo - UT MD Anderson Cancer Center, Houston, TX
Translocation (6;9)- Related Myeloid Neoplasms in Children Are Diseases of Older Children with Variable Presentations.
(1291)
J Joseph, A Sheehan, X Lu, T Elghetany - Baylor College of Medicine, Houston, TX; Texas Children's Hospital, Houston
Characterization of Clonal Abnormalities in Refractory Anemia with Ringed Sideroblasts and Associated Thrombocytosis (RARS-T).
(1249)
J De - Genoptix Medical Laboratory, Carlsbad, CA
Myelodysplastic/Myeloproliferative Neoplasm (MDS/MPN) with Isolated Isochromosome 17q [i(17q)]: An Aggressive Entity with Prominent Multilineage Dysplasia and Wild Type NPM1.
(1293)
R Kanagal Shamannna, CC Yin, G Lu, M Nguyen, D Hoehn, G Garcia-Manero, S Vadhan-Raj, LJ Medeiros, C Bueso-Ramos - UT MD Anderson Cancer Center, Houston
Developing Epigenetic Profiling-Based Biomarkers for Flow Cytometry, Immunohistochemistry and Liquid-ChIP Assays in Myelodyplastic Syndrome.
(1236)
JX Cheng, E Kleinbrink, J Hummel, S-S Kim - University of Michigan, Ann Arbor
EXEL-8232, a Small Molecule JAK2 inhibitor, Effectively Treats Thrombocytosis and Extramedullary Hematopoiesis in a Murine Model of Myeloproliferative Disease Induced by MPLW515L.
(1395)
G Wernig, M Kharas, D Clary, G Gilliland, T George - Stanford Hospital & Clinics, Stanford University Medical School, CA; Brigham & Women's Hospital, Harvard Medical School, Boston, MA; Exelixis, San Francisco, CA
Distinct Histological Patterns of Splenic Extramedullary Hematopoiesis in Myeloproliferative Neoplasms Correlate with Clinical Behavior.
(1344)
S Prakash, R Hoffman, S Barouk, DM Knowles, A Orazi - Weill Cornell Medical College, New York; Mount Sinai School of Medicine, New York
Expression of 2D7, a Unique Marker of Basophils in Myeloproliferative Neoplasms.
(1216)
A Arredondo, C Jennings, U Sundram, ZS Lu, T George - Stanford University, CA
Immunophenotypic Analysis of Systemic Mastocytosis by High-Sensitivity Flow Cytometry.
(1299)
S Kondratiev, B Li, DM Dorfman, O Pozdnyakova - Brigham and Women's Hospital, Boston, MA
CD30 Expression in Mastocytosis.
(1215)
AR Arredondo, CD Jennings, L Shier, U Sundram, J Gotlib, TI George - Stanford University School of Medicine, CA; University of Alberta Hospital, Edmonton, Canada
FISH Is Necessary To Distinguish MLLT10/MLL Fusion from MLLT10/CALM Fusion in Acute Leukemia with Chromosome 10p and 11q Rearrangements.
(1374)
WR Sukov, RA Knudson, JG Keefe, RP Ketterling - Mayo Clinic, Rochester, MN
Cryptic Insertional PML-RARA Translocations.
(1297)
JM Klco, JS Welch, M Evenson, JE Payton, P Westervelt, JL Frater, TJ Ley, S Kulkarni - Washington University School of Medicine, St. Louis, MO
Utility of CD11a and CD18 in the Diagnosis of Acute Promyelocytic Leukemia by Flow Cytometric Immunophenotyping.
(1417)
Y Zhou, JL Jorgensen, SA Wang, LJ Medeiros, SN Konoplev - University of Texas MD Anderson Cancer Center, Houston
Diagnostic Value of CD31 Immunohistochemistry in Evaluation of Acute Myeloid Leukemia with Megakaryocytic Differentiation.
(1372)
M Su, D Rakheja, H-Y Wang, F Fuda, W Chen - UT Southwestern Medical Center, Dallas, TX
Prognostic Impact of Immunophenotyping in Elderly Acute Myeloid Leukemia with Normal Karyotype.
(1288)
A Jiang, J Brandwein, H Chang - University Health Network, Toronto, Canada
The Use of Pro-Apoptotic Marker, FoxO3 To Distinguish Erythroid Dominant Malignancies.
(1252)
R Dewar, R Khosravi-Far - Beth Israel Deaconess Medical Center & Harvard Medical School, Boston, MA; Harvard Medical School, Boston, MA
Cytochemical and/or Immunohistochemical Staining for Myeloperoxidase Are Essential in the Work-Up of Mixed Phenotype Acute Leukemia.
(1255)
J Emmons, JS Willis, NJ Karandikar, FS Fuda - University of Texas Southwestern Medical School, Dallas
Mixed Phenotype Acute Leukemia (MPAL): A Study of 61 Cases Using WHO and EGIL Criteria.
(1393)
OK Weinberg, M Seetharam, L Ren, A Alizadeh, DA Arber - Stanford University, CA
Utility of CD117 Expression in the Diagnosis of T/Myeloid Mixed Phenotype Acute Leukemia.
(1398)
JS Willis, J Emmons, NJ Karandikar, FS Fuda - University of Texas Southwestern Medical School, Dallas
Use of Classic and Novel Immunohistochemical Markers in the Diagnosis of Cutaneous Myeloid Sarcoma.
(1213)
C Amador-Ortiz, MY Hurley, GK Ghahramani, S Frisch, KM Jeffery, AC Lind, T-D Nguyen, A Hassan, FH Kreisel, JL Frater - Washington University, St. Louis, MO; St. Louis University, MO
Molecular and Clinicopathologic Characterization of De Novo AML with Isolated Trisomy 4.
(1217)
A Bains, G Lu, H Yao, R Luthra, LJ Medeiros, RL Sargent - UT-MD Anderson Cancer Center, Houston, TX
High Incidence of IDH Mutations in Acute Myeloid Leukemia with Cup-Like Nuclei.
(1346)
D Rakheja, R Collins, M Su, M Mitui, NJ Karandikar, W Chen - UT Southwestern Medical Center, Dallas, TX
button next to any title to add to Itinerary Planner...
Add
